- Nachrichtendetail
-
10.05.2024 15:51:36 - dpa-AFX: *FDA GRANTS BREAKTHROUGH STATUS TO NOVARTIS' SCEMBLIX FOR NEWLY DIAGNOSED CML IN CHRONIC PHASE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NOVARTIS NAM. SF 0,49 | 904278 | Hamburg | 0,000 | 26.05.24 13:08:53 | ±0,000 | ±0,00% | 0,000 | 0,000 | 0,000 | 80,190 |
